Association of Variant rs7903146 (C/T) Single Nucleotide Polymorphism of TCF7L2 Gene With Impairment in Wound Healing Among North Indian Type 2 Diabetes Population
Restricted accessResearch articleFirst published online December, 2013
Association of Variant rs7903146 (C/T) Single Nucleotide Polymorphism of TCF7L2 Gene With Impairment in Wound Healing Among North Indian Type 2 Diabetes Population
The variants of transcription factor 7-like 2 (TCF7L2) gene have been shown to be associated with type 2 diabetes mellitus (T2DM) and its several secondary complications. Here, we aimed to examine the possible role of one of the common variant of this gene, rs7903146 (C/T), with impairment of wound healing in cases with T2DM. A total of 750 individuals, including 322 patients with T2DM and 120 patients with diabetic foot ulcers (DFUs) and 308 controls, were analyzed for rs7903146 variant of the TCF7L2 gene. Genotyping was done by polymerase chain reaction–restriction fragment length polymorphism. For rs7903146 variant, TT genotype frequency in patients with DFU was 10.8% and in controls was 5.2%. Risk genotype (TT) frequencies showed statistically significant difference between the DFU patients versus non-DM control group (odds ratio = 2.44, P = .037, 95% confidence interval = 1.05-5.64) compared with nonrisk genotype (CC + CT). In the present study, a positive significant association between DFU and the TT genotype of rs7903146 (C/T) variant of TCF7L2 gene was found.
ReavenGM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2.
World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation (WHO/NCD/NCS/99.2). Geneva, Switzerland: World Health Organization; 1999.
3.
International Diabetes Federation. IDF Diabetes Atlas. 4th ed.Brussels, Belgium: International Diabetes Federation; 2009.
4.
FowlerMJ. Microvascular and macrovascular complications of diabetes. Clin Diab. 2008;26:77-82.
5.
ReiberGELedousWE. Epidemiology of diabetic foot ulcers and amputations: evidence for prevention. In: RWilliamsWHermanALKinmonthNJWareham, eds. The Evidence Base for Diabetes Care. Chichester, England: Wiley; 2002:641-666.
6.
BoultonAJVileikyteLRagnarson-TennvallGApelqvistJ. The global burden of diabetic foot disease. Lancet. 2005;366:1719-1724.
7.
BoultonJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia. 2004;47:1343-1353.
8.
MaleckiTM. Genetics of type 2 diabetes mellitus. Diab Res Clin Pract. 2005;68(suppl 1):S10-S21.
9.
LyuJJooCK. Wnt-7a up-regulates matrix metalloproteinase-12 expression and promotes cell proliferation in corneal epithelial cells during wound healing. J Biol Chem. 2005;280:21653-21660.
10.
PaulRGTarltonJFPurslowPP. Biomechanical and biochemical study of a standardized wound healing model. Int J Biochem Cell Biol. 1997;29:211-220.
11.
SinghKAgrawalNKGuptaSKSinghK. A functional SNP-1562C>T in the matrix metalloproteinases-9 promoter is associated with type 2 diabetes and diabetic foot ulcers. Int J Lower Extrem Wounds. doi 10.1177/1534734613493289.
12.
LaeremansHRensenSSOttenheijmHCSmitsJFBlankesteijnWM. Wnt/frizzled signalling modulates the migration and differentiation of immortalized cardiac fibroblasts. Cardiovasc Res. 2010;87:514-523.
13.
CheonSSWeiQGurungA. Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing. FASEB J. 2006;20:692-701.
14.
PrunierCHocevarBAHowePH. Wnt signaling: physiology and pathology. Growth Factors. 2004;22:141-150.
15.
HanssonOZhouYRenströmEOsmarkP. Molecular function of TCF7L2: consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes. Curr Diab Rep. 2010;10:444-451.
16.
LyssenkoVLupiRMarchettiP. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007;117:2155-2163.
17.
BodhiniDRadhaVDharMNarayaniNMohanV. The rs12255372 (G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. Metabolism. 2007;56:1174-1178.
18.
DupontWDPlummerWD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19:589-601.
19.
MillerSADykesDDPoleskyHF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
20.
MoczulskiDGawlikBAugustRStrojekKGrzeszczakW. TCF7L2 gene is associated with type 2 diabetes in Polish population. Diabetol Doświadczalna Klin. 2007;7:109-111.
21.
ZhangDLGuLJLiuL. Effect of Wnt signaling pathway on wound healing. Biochem Biophys Res Commun. 2009;378:149-151.
22.
LabusMStirkCMThompsonWDMelwinWT. Expression of Wnt genes in early wound healing. Wound Repair Regen. 1998;6:58-64.
23.
ItoMYangZAndlT. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature. 2007;447:316-321.
24.
StojadinovicOBremHVouthounisC. Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167:59-69.
25.
GurungAUddinFHillRPFergusonPCAlmanBA. β-Catenin is a mediator of the response of fibroblasts to irradiation. Am J Pathol. 2009;174:248-255.
26.
YiFBrubakerPLJinT. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3 beta. J Biol Chem. 2005;280:1457-1464.
27.
DuggiralaRBlangeroJAlmasyL. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet. 1999;164:1127-1140.
28.
GrantSFThorleifssonGReynisdottirI. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320-323.
29.
JinTLiuL. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol. 2008;22:2383-2392.
30.
SinghKSinghVKAgrawalNKGuptaSKSinghK. Association of toll-like receptor 4 polymorphisms with diabetic foot ulcers and application of artificial neural network in DFU risk assessment in type 2 diabetes patients. Biomed Res Int. 2013;2013:318686.
31.
MirKAPugazhendhiSPaulMJNairARamakrishnaBS. Heat-shock protein 70 gene polymorphism is associated with the severity of diabetic foot ulcer and the outcome of surgical treatment. Br J Surg. 2009;96:1205-1209.
32.
CauchiSEl AchhabYChoquetH. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85:777-782.
33.
ReesSDBellarySBrittenAC. Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population. BMC Med Genet. 2008;9:8.
34.
BuraczynskaMSwatowskiAMarkowska-GosikDKuczmaszewskaAKsiazekA. Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diab Res Clin Pract. 2011;93:390-395.
35.
CiccacciCDi FuscoDCacciottiL. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy [published online July 28, 2012]. Acta Diabetol. doi:10.1007/s00592-012-0418-x.
36.
MuendleinASaelyCHGeller-RhombergS. Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis. PLoS One. 2011;6:e17978.
37.
ChandakGRJanipalliCSBhaskarS. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia. 2007;50:63-67.
